SciNeuro Pharmaceuticals Employee Directory
Biotechnology ResearchMaryland, United States11-50 Employees
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on therapies for neurodegenerative diseases. Based in Rockville, Maryland and founded in 2020, the company has developed a pipeline that moves from discovery to clinical development, targeting three disease-driving mechanisms: neurovascular inflammation, proteinopathy, and immune response. Its objective is to deliver disease-modifying treatment options for Alzheimer's disease, Parkinson's disease, and other central nervous system disorders. Recently, SciNeuro identified a new de novo amyloid beta antibody program and announced an exclusive worldwide licensing and collaboration with Novartis Pharma AG to advance this program for Alzheimer's disease. That collaboration with a major pharmaceutical partner indicates external support for advancing its CNS-focused research.